About Us - Rare Disease Diagnostics

Find Out More About Us

Our Story

Early and accurate diagnosis of rare diseases is crucial for timely initiation of appropriate therapeutics and interventions. Our company is a research service provider in the field of rare disease diagnostics, dedicated to developing advanced in vitro diagnostic (IVD) products to tackle the challenges of rare disease diagnosis. Our goal is to drive innovation in rare disease diagnostics, expediting your journey from diagnostic research to commercialization.

What We Do

Drawing on our extensive expertise and cutting-edge technology platforms, we provide one-stop solutions for rare disease diagnostic research. Our services encompass the development of IVD kits and equipment, enhancing the efficiency and accuracy of rare disease diagnosis. We are dedicated to advancing point-of-care testing (POCT) and companion diagnostics, extending complete support to facilitate swift point-of-care detection and personalized therapeutics for rare diseases.

Our Mission

Our Strategy

Our Vision

Our Commitment

Our mission is to revolutionize rare disease diagnostics and drive advancements in the field by providing innovative and reliable solutions.

Our strategy is to establish partnerships with leading researchers and expert groups to leverage collective knowledge and resources in rare disease diagnostics.

Our vision is to be a global leader in rare disease diagnostic development, providing unparalleled support and services for rare disease diagnostic research.

Our commitment is customer-centricity. We are committed to building long-term relationships with our customers, providing exceptional support, and exceeding their expectations.

Your Partner in Rare Disease Diagnosis Development

We are eager to leverage our expertise and comprehensive range of resources to support your rare disease diagnostic research projects. Our rare disease diagnostic development services are specifically tailored to meet your unique requirements. We are excited about the opportunity to collaborate closely with our global peers, pooling our collective knowledge and efforts to drive advancements in the development of advanced diagnostic tools for rare diseases.